Diagnosis and treatment of adrenal insufficiency including adrenal crisis: a Japan Endocrine Society clinical practice guideline [Opinion]
- 1 January 2016
- journal article
- practice guideline
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 63 (9), 765-784
- https://doi.org/10.1507/endocrj.ej16-0242
Abstract
This clinical practice guideline of the diagnosis and treatment of adrenal insufficiency (AI) including adrenal crisis was produced on behalf of the Japan Endocrine Society. This evidence-based guideline was developed by a committee including all authors, and was reviewed by a subcommittee of the Japan Endocrine Society. The Japanese version has already been published, and the essential points have been summarized in this English language version. We recommend diagnostic tests, including measurement of basal cortisol and ACTH levels in combination with a rapid ACTH (250 μg corticotropin) test, the CRH test, and for particular situations the insulin tolerance test. Cut-off values in basal and peak cortisol levels after the rapid ACTH or CRH tests are proposed based on the assumption that a peak cortisol level ≥18 μg/dL in the insulin tolerance test indicates normal adrenal function. In adult AI patients, 15-25 mg hydrocortisone (HC) in 2-3 daily doses, depending on adrenal reserve and body weight, is a basic replacement regime for AI. In special situations such as sickness, operations, pregnancy and drug interactions, cautious HC dosing or the correct choice of glucocorticoids is necessary. From long-term treatment, optimal diurnal rhythm and concentration of serum cortisol are important for the prevention of cardiovascular disease and osteoporosis. In maintenance therapy during the growth period of patients with 21-hydroxylase deficiency, proper doses of HC should be used, and long-acting glucocorticoids should not be used. Education and carrying an emergency card are essential for the prevention and rapid treatment of adrenal crisis.Keywords
This publication has 90 references indexed in Scilit:
- Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiencyNature Genetics, 2012
- Health Status of Adults with Congenital Adrenal Hyperplasia: A Cohort Study of 203 PatientsJournal of Clinical Endocrinology & Metabolism, 2010
- Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelineJournal of Clinical Endocrinology & Metabolism, 2010
- A pharmacokinetic and pharmacodynamic study of delayed‐ and extended‐release hydrocortisone (ChronocortTM) vs. conventional hydrocortisone (CortefTM) in the treatment of congenital adrenal hyperplasiaClinical Endocrinology, 2010
- Modified-Release Hydrocortisone to Provide Circadian Cortisol ProfilesJournal of Clinical Endocrinology & Metabolism, 2009
- Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus StatementJournal of Clinical Endocrinology & Metabolism, 2008
- Approach to the Adult with Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyJournal of Clinical Endocrinology & Metabolism, 2008
- Long-term mortality in the United States cohort of pituitary-derived growth hormone recipientsThe Journal of Pediatrics, 2004
- Perioperative Glucocorticoid Coverage A Reassessment 42 Years After Emergence of a ProblemAnnals of Surgery, 1994
- The plasma ACTH, AVP, CRH and catecholamine responses to conventional and laparoscopic cholecystectomyClinical Endocrinology, 1993